CLColgate-Palmolive

$94.03+23% 1Y

Is the price fair?

Watch

A demanding price: at the top of its own P/E range and rich vs its sector.

2 to watch, 1 neutral
What the price assumes~+5% a year

Priced for ~5% a year FCF growth. Roughly in line with its three-year revenue growth of 4% a year.

Vs its own P/E rangedearer than 93% of its own historyderived

Expensive vs its own history: P/E 37.2 vs a 24.9 median over 41 quarters (+49% vs median).

Vs sector (EV/EBIT)26.0×

Sector median 17.7× across 76 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 79% of the market
FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CL's price assumes

Colgate-Palmolive trades at 37.2× earnings against 24.3× for the median Household & Personal Products name, more expensive than its own group.

37.2

Trailing P/E · Household & Personal Products median 24.3 · 1.53× the median: the market pays up for this one

Price / sales
3.56

Price / sales · today's price, trailing year to Jun 30, 2026

Free cash flow yield
5.1%

Free cash flow yield · Household & Personal Products median 5.1%

Growth the price implies
+5.3%

Growth the price implies · The price pays for +5.3% free cash flow growth a year for a decade; the business has delivered +18% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
318
EV / EBITtoday's price, trailing year to Jun 30, 2026
26.0
EV / salestoday's price, trailing year to Jun 30, 2026
3.87
Consumer Defensive median P/E140 names
21.7
Household & Personal Products median P/E18 names
24.3
Free cash flow, trailing twelve months
$3.86B
Market capitalisation797.2 million shares, counted Jun 30, 2026
$75.0B
3-year revenue growth
+4.1%
3-year free cash flow growth
+18%
What the market has paid for these earnings: 41 quarters of its own multiple × $2.53 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$55.59
Its own P/E history, median$63.02
Its own P/E history, upper quartile$75.09
52-week range$74.06 – $98.53
Today$94.03

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.